<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; HPV16</title>
	<atom:link href="http://oralcancernews.org/wp/tag/hpv16/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Mon, 21 May 2012 12:57:26 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Actor&#8217;s Diagnosis Puts Spotlight on Oral Cancer</title>
		<link>http://oralcancernews.org/wp/actors-diagnosis-puts-spotlight-on-oral-cancer-2/</link>
		<comments>http://oralcancernews.org/wp/actors-diagnosis-puts-spotlight-on-oral-cancer-2/#comments</comments>
		<pubDate>Tue, 15 May 2012 21:17:41 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[Michael Douglas]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[The Oral Cancer Foundation]]></category>
		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=13054</guid>
		<description><![CDATA[Source: DrBicuspid.com May 9, 2012 &#8212; Actor Michael Douglas&#8217; recent revelation that he has stage IV oropharyngeal cancer has highlighted the growing incidence of oral cancer, and experts say dentists can help stem the alarming increase of the disease by checking for it during routine examinations. The actor&#8217;s cancer includes a walnut-sized tumor at the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/actors-diagnosis-puts-spotlight-on-oral-cancer-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>April: Oral Cancer Awareness Month</title>
		<link>http://oralcancernews.org/wp/april-oral-cancer-awareness-month/</link>
		<comments>http://oralcancernews.org/wp/april-oral-cancer-awareness-month/#comments</comments>
		<pubDate>Mon, 02 Apr 2012 16:47:20 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[OCF In The News]]></category>
		<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[alcohol]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oral cancer awareness month]]></category>
		<category><![CDATA[Oropharynx]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>
		<category><![CDATA[The American Cancer Society]]></category>
		<category><![CDATA[The Oral Cancer Foundation]]></category>
		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12733</guid>
		<description><![CDATA[Source: Aspen Dental April is Oral Cancer Awareness Month. According to Brian Hill, founder and executive director of the Oral Cancer Foundation, as many as 40,000 people in the United States will be told they have oral or pharyngeal cancer in 2012. Some of them may be sitting in your dental chair today. With one [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/april-oral-cancer-awareness-month/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Combo HPV Diagnostic Test for Head and Neck Cancer Outperforms Other Tests</title>
		<link>http://oralcancernews.org/wp/combo-hpv-diagnostic-test-for-head-and-neck-cancer-outperforms-other-tests/</link>
		<comments>http://oralcancernews.org/wp/combo-hpv-diagnostic-test-for-head-and-neck-cancer-outperforms-other-tests/#comments</comments>
		<pubDate>Thu, 06 Oct 2011 18:23:00 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Clinical Cancer Research]]></category>
		<category><![CDATA[DNA qPCR]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[oropharyngeal squamous cell carcinomas]]></category>
		<category><![CDATA[p16 immunohistochemistry]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11891</guid>
		<description><![CDATA[SOURCE: American Association for Cancer Research PHILADELPHIA &#8212; October 3, 2011 &#8212; Researchers have determined that a combination of P16 immunohistochemistry and DNA qPCR to test for viral E6 can accurately determine the oropharyngeal squamous cell carcinomas which derive from human papillomavirus (HPV) type 16, according to a study published in Clinical Cancer Research. &#8220;This [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/combo-hpv-diagnostic-test-for-head-and-neck-cancer-outperforms-other-tests/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Evaluation of Human Papilloma Virus Diagnostic Testing in Oropharyngeal Squamous Cell Carcinoma: Sensitivity, Specificity, and Prognostic Discrimination</title>
		<link>http://oralcancernews.org/wp/evaluation-of-human-papilloma-virus-diagnostic-testing-in-oropharyngeal-squamous-cell-carcinoma-sensitivity-specificity-and-prognostic-discrimination/</link>
		<comments>http://oralcancernews.org/wp/evaluation-of-human-papilloma-virus-diagnostic-testing-in-oropharyngeal-squamous-cell-carcinoma-sensitivity-specificity-and-prognostic-discrimination/#comments</comments>
		<pubDate>Tue, 04 Oct 2011 18:21:58 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[E6 RNA]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[oropharyngeal squamous cell carcinoma]]></category>
		<category><![CDATA[p16 immunohistochemistry]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11884</guid>
		<description><![CDATA[Source: Clinical Cancer Research Abstract Purpose: Human papillomavirus-16 (HPV16) is the causative agent in a biologically distinct subset of oropharyngeal squamous cell carcinoma (OPSCC) with highly favorable prognosis. In clinical trials, HPV16 status is an essential inclusion or stratification parameter, highlighting the importance of accurate testing. Experimental Design: Fixed and fresh-frozen tissue from 108 OPSCC [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/evaluation-of-human-papilloma-virus-diagnostic-testing-in-oropharyngeal-squamous-cell-carcinoma-sensitivity-specificity-and-prognostic-discrimination/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Improved HPV Diagnostic Test for Head and Neck Cancer</title>
		<link>http://oralcancernews.org/wp/new-improved-hpv-diagnostic-test-for-head-and-neck-cancer/</link>
		<comments>http://oralcancernews.org/wp/new-improved-hpv-diagnostic-test-for-head-and-neck-cancer/#comments</comments>
		<pubDate>Tue, 04 Oct 2011 18:07:06 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[American Association for Cancer Research]]></category>
		<category><![CDATA[Clinical Cancer Research]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[oropharyngeal squamous cell carcinoma]]></category>
		<category><![CDATA[p16]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11881</guid>
		<description><![CDATA[Source: EurekAlert! Philadelphia &#8212; Researchers have determined that a combination of P16 immunohistochemistry and DNA qPCR to test for viral E6 can accurately determine the oropharyngeal squamous cell carcinoma, a form of head and neck cancer, which derive from HPV16, according to a study published in Clinical Cancer Research, a journal of the American Association [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/new-improved-hpv-diagnostic-test-for-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Increase in oral cancers linked to HPV</title>
		<link>http://oralcancernews.org/wp/increase-in-oral-cancers-linked-to-hpv/</link>
		<comments>http://oralcancernews.org/wp/increase-in-oral-cancers-linked-to-hpv/#comments</comments>
		<pubDate>Mon, 03 Oct 2011 20:51:20 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[alcohol]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[oral sex]]></category>
		<category><![CDATA[survival rates]]></category>
		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11856</guid>
		<description><![CDATA[Source: thechart.blogs.cnn.com Author: Saundra Young &#8211; CNN Medical Senior Producer The human papillomavirus is contributing to the growing number of head and neck cancers in the United States, according to a new study Monday in the Journal of Clinical Oncology. The study found that the number of cases of oropharyngeal cancer &#8211; cancers of the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/increase-in-oral-cancers-linked-to-hpv/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>HIM study looks at HPV infection and clearance in men</title>
		<link>http://oralcancernews.org/wp/him-study-looks-at-hpv-infection-and-clearance-in-men/</link>
		<comments>http://oralcancernews.org/wp/him-study-looks-at-hpv-infection-and-clearance-in-men/#comments</comments>
		<pubDate>Sat, 05 Mar 2011 00:37:35 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Anna Giuliano]]></category>
		<category><![CDATA[HIM study]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV16]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=10615</guid>
		<description><![CDATA[Medscape Oncology News By  Nick Mulcahy March 1, 2011 — Half of all the men participating in a natural history study of human papillomavirus (HPV) were infected with some strain of HPV at some point during study period, according to the results of a new study published online March 1 in the Lancet. The HPV in [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/him-study-looks-at-hpv-infection-and-clearance-in-men/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Oropharyngeal cancer epidemic and human papillomavirus</title>
		<link>http://oralcancernews.org/wp/oropharyngeal-cancer-epidemic-and-human-papillomavirus/</link>
		<comments>http://oralcancernews.org/wp/oropharyngeal-cancer-epidemic-and-human-papillomavirus/#comments</comments>
		<pubDate>Sun, 07 Nov 2010 16:30:32 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[alcohol]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[smoking]]></category>
		<category><![CDATA[vaccination]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=9739</guid>
		<description><![CDATA[Source: www.foodconsumer.org Authors: Torbjörn Ramqvist and Tina Dalianis Abstract A growing body of research shows that human papillomavirus (HPV) is a common and increasing cause of oropharyngeal squamous cell carcinoma (OSCC). Thus, the International Agency for Research against Cancer has acknowledged HPV as a risk factor for OSCC, in addition to smoking and alcohol consumption. [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/oropharyngeal-cancer-epidemic-and-human-papillomavirus/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>European Commission amends licence for Cervarix</title>
		<link>http://oralcancernews.org/wp/european-commission-amends-licence-for-cervarix/</link>
		<comments>http://oralcancernews.org/wp/european-commission-amends-licence-for-cervarix/#comments</comments>
		<pubDate>Wed, 25 Aug 2010 12:27:36 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV 31]]></category>
		<category><![CDATA[HPV 45]]></category>
		<category><![CDATA[HPV-33]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=9334</guid>
		<description><![CDATA[Source: www.pharmpro.com Author: press release GlaxoSmithKline (GSK) confirmed today that the European Commission has granted Marketing Authorisation to amend the licence for its cervical cancer vaccine, Cervarix®. The approval from the European Commission is important as it recognises the extent of cervical cancer protection demonstrated by Cervarix®, which was not highlighted by the previous indication. [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/european-commission-amends-licence-for-cervarix/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV is changing the face of head and neck cancers</title>
		<link>http://oralcancernews.org/wp/hpv-is-changing-the-face-of-head-and-neck-cancers/</link>
		<comments>http://oralcancernews.org/wp/hpv-is-changing-the-face-of-head-and-neck-cancers/#comments</comments>
		<pubDate>Sun, 27 Jun 2010 12:26:29 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[biopsy]]></category>
		<category><![CDATA[brush sampling]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV positive]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[lymphocytes]]></category>
		<category><![CDATA[prognosis]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[risk factor]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[smoking]]></category>
		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8940</guid>
		<description><![CDATA[Source: www.hemonctoday.com Author:  Christen Cona In February, at the Multidisciplinary Head and Neck Cancer Symposium in Chandler, Ariz., Maura Gillison, MD, PhD, professor and Jeg Coughlin Chair of Cancer Research at The Ohio State University in Columbus, presented data that showed that the proportion of all head and neck squamous cell cancers that were of [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-is-changing-the-face-of-head-and-neck-cancers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BT Pharma secures EUR 13.1million (USD 17.7 million) in capital funding and changes its name to Genticel</title>
		<link>http://oralcancernews.org/wp/bt-pharma-secures-eur-13-1million-usd-17-7-million-in-capital-funding-and-changes-its-name-to-genticel/</link>
		<comments>http://oralcancernews.org/wp/bt-pharma-secures-eur-13-1million-usd-17-7-million-in-capital-funding-and-changes-its-name-to-genticel/#comments</comments>
		<pubDate>Wed, 10 Mar 2010 04:40:51 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[HPV18]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[immunotherapies]]></category>
		<category><![CDATA[ProCervix]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8085</guid>
		<description><![CDATA[Source: pharmalive.com/News Author: press release BT Pharma, a biopharmaceutical company developing innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today that it has raised EUR 13.1 million in additional funding and changed its name to Genticel. AGF Private Equity led the round, which brought in three new investors, IRDI (Institut Régional [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/bt-pharma-secures-eur-13-1million-usd-17-7-million-in-capital-funding-and-changes-its-name-to-genticel/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma</title>
		<link>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma-2/</link>
		<comments>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma-2/#comments</comments>
		<pubDate>Sun, 20 Dec 2009 06:04:23 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cohort]]></category>
		<category><![CDATA[disease-free survival]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[human papilloma virus]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7618</guid>
		<description><![CDATA[Source: Journal of Clinical Oncology, Vol 27, No 36 (December 20), 2009: pp. 6213-6221 Authors: Wei Shi et al. Purpose: A significant proportion of oropharyngeal squamous cell carcinomas (OSCC) are associated with the human papilloma virus (HPV), particularly HPV16. The optimal method for HPV determination on archival materials however, remains unclear. We compared a quantitative [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma</title>
		<link>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma/</link>
		<comments>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma/#comments</comments>
		<pubDate>Thu, 05 Nov 2009 14:30:00 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[epidermal growth factor]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[immunohistochemistry]]></category>
		<category><![CDATA[p53]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7201</guid>
		<description><![CDATA[Source: Journal of Clinical Oncology, 10.1200/JCO.2009.23.1670 Author: Wei Shi et al. Purpose: A significant proportion of oropharyngeal squamous cell carcinomas (OSCC) are associated with the human papilloma virus (HPV), particularly HPV16. The optimal method for HPV determination on archival materials however, remains unclear. We compared a quantitative real-time polymerase chain reaction (qRT-PCR) assay for HPV16 [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PMH finding may help some tonsil cancer patients avoid chemotherapy</title>
		<link>http://oralcancernews.org/wp/pmh-finding-may-help-some-tonsil-cancer-patients-avoid-chemotherapy/</link>
		<comments>http://oralcancernews.org/wp/pmh-finding-may-help-some-tonsil-cancer-patients-avoid-chemotherapy/#comments</comments>
		<pubDate>Wed, 04 Nov 2009 19:27:48 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[radiation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7178</guid>
		<description><![CDATA[Source: www.sciencecodex.com Author: staff Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer (&#8220;tonsil cancer&#8221;) harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. For some patients, this may mean successful treatment with radiation alone and avoiding the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/pmh-finding-may-help-some-tonsil-cancer-patients-avoid-chemotherapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV data may aid vaccine&#8217;s effectiveness</title>
		<link>http://oralcancernews.org/wp/hpv-data-may-aid-vaccines-effectiveness-2/</link>
		<comments>http://oralcancernews.org/wp/hpv-data-may-aid-vaccines-effectiveness-2/#comments</comments>
		<pubDate>Mon, 13 Apr 2009 16:08:21 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[HPV18]]></category>
		<category><![CDATA[HPV31]]></category>
		<category><![CDATA[HPV33]]></category>
		<category><![CDATA[HPV45]]></category>
		<category><![CDATA[human papillomavirus]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=4366</guid>
		<description><![CDATA[Source: health.usnews.com Author: staff The majority of invasive cervical cancers in New Mexico in the 1980s and 1990s contained DNA from human papillomavirus type 16 (HPV16) and HPV type 18 (HPV18), says a new study. It also found that women diagnosed with HPV16- or HPV18-positive cancers were an average of five years younger than those [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-data-may-aid-vaccines-effectiveness-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

